Insight in Spain

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

Stakeholder Opinions: Ovarian Cancer - Approaching the era of molecular targeted therapy

Key issues in the ovarian cancer market, including forecast epidemiology, current treatment trends and controversies, unmet needs, insight into pipeline activity and stakeholder opinion.

Published By Datamonitor
12 Jul 2010 $3800
Buy
Report
Report

Pipeline and Commercial Insight: Migraine - Challenges ahead for first-in-class developments

Analysis of the current and future migraine market. Includes sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.

Published By Datamonitor
13 Jul 2010 $15200
Buy
Brief
Brief

IBM Claims Green Space

IBM has taken another step into the business into 'green IT' by estalishing the Green Sigmas coalition. This briefs outlines the gains for IBM from maintaining their focus on sustainability as a corporate priority.

Published By Datamonitor
14 Jul 2010 $895
Buy
Report
Report

Pipeline and Commercial Insight: Insomnia - Future of innovative orexin drug class in doubt

Analysis of the current and future insomnia market. Includes sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.

Published By Datamonitor
14 Jul 2010 $15200
Buy
Report
Report

Pipeline and Commercial Insight: Allergic Rhinitis - Immunotherapy growth surpassed by generic erosion

Overview of the current and future allergic rhinitis market, including in-depth analysis of changes in the market, 10 year indication specific sales forecasts of key classes, and a 10 year interactive patient based forecast for immunotherapy.

Published By Datamonitor
14 Jul 2010 $15200
Buy
Report
Report

Commercial Insight: Osteoporosis - Market players maximize revenue growth before the next challenging phase

Comprehensive analysis of the current and future osteoporosis drug market, with country-specific forecasts to 2019 of marketed, generic, and key pipeline drugs in the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK).

Published By Datamonitor
21 Jul 2010 $15200
Buy
Report
Report

Pipeline Insight: Osteoporosis - Bone building drugs become the heart of the pipeline

In-depth analysis of the osteoporosis drug pipeline, including a review of clinical unmet needs, assessment of the clinical and commercial prospects of 12 key late-stage agents, sales forecasts to 2019 and key opinion leader insight.

Published By Datamonitor
21 Jul 2010 $11400
Buy
Report
Report

Global Foodservice Analyzer

Introducing Datamonitor's new application for sizing and segmenting the global foodservice market

Published By Datamonitor
22 Jul 2010 $100
Buy
Report
Report

Offshore Excellence: Building the proposition your customers most want

This report explores the ideal offshore proposition, giving clients a blueprint against which they can judge their own business and ensure they are most competitive in this changing market.

Published By Datamonitor
23 Jul 2010 $4495
Buy
Brief
Brief

Aviva Case Study: Tell Us Your Story

Aviva's Tell Us Your Story marketing campaign is an innovative approach to reengaging consumers with the long term savings and insurance market, which players in all other areas of FS can draw inspiration from.

Published By Datamonitor
29 Jul 2010 $1695
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.